Dr. Robert Hsu discusses the molecular characterization of lung carcinomas expressing KK-LC-1, focusing on the differential expression in adenocarcinoma vs. squamous cell carcinoma, tumor mutational burden, and implications for adoptive cell therapy in non-small cell lung cancer. The podcast also explores KKLC1 expression in lung carcinomas, immune infiltrates, potential cell therapy targeting, collaborations for protein expression evaluation, and drug development efforts.